The newly formed SPAC in an amended S-1 filing registered an additonal 2 million units at $10 each to bump up its raise to $120 million — up from the initial registration of 10 million units.
Omega Alpha intends to focus on the healthcare or healthcare-related industries. “In particular, we expect to target North American or European companies in the biotechnology sector where our management team has extensive investment experience,” the SPAC noted in the filing.
The SPAC plans to list on the Nasdaq under OMEG. Read more.
